Cellular mechanisms of IL-17-induced blood-brain barrier disruption
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Recently T-helper 17 (Th17) cells were demonstrated to disrupt the blood-brain barrier (BBB) by the action of IL-17A. The aim of the present study was to examine the mechanisms that underlie IL-17A-induced BBB breakdown. Barrier integrity was analyzed in the murine brain endothelial cell line bEnd.3 by measuring the electrical resistance values using electrical call impedance sensing technology. Furthermore, in-cell Western blots, fluorescence imaging, and monocyte adhesion and transendothelial migration assays were performed. Experimental autoimmune encephalomyelitis (EAE) was induced in C57BL/6 mice. IL-17A induced NADPH oxidase- or xanthine oxidase-dependent reactive oxygen species (ROS) production. The resulting oxidative stress activated the endothelial contractile machinery, which was accompanied by a down-regulation of the tight junction molecule occludin. Blocking either ROS formation or myosin light chain phosphorylation or applying IL-17A-neutralizing antibodies prevented IL-17A-induced BBB disruption. Treatment of mice with EAE using ML-7, an inhibitor of the myosin light chain kinase, resulted in less BBB disruption at the spinal cord and less infiltration of lymphocytes via the BBB and subsequently reduced the clinical characteristics of EAE. These observations indicate that IL-17A accounts for a crucial step in the development of EAE by impairing the integrity of the BBB, involving augmented production of ROS.-Huppert, J., Closhen, D., Croxford, A., White, R., K…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“IL-17 impairs blood–brain barrier integrity, allowing for more immune cells to cross into the CNS [127,128].”
From The Role of Cortisol in Chronic Stress, Neurodegenerative Diseases, and Psychological Disorders (2023) · cites this paper as [127]
In the citing paper
“In turn, IL-17 further impairs BBB integrity, thus allowing more immune cells and cytokines to gain easy access to the CNS [65, 66].”
From Chronic stress-induced depression requires the recruitment of peripheral Th17 cells into the brain (2022) · cites this paper as [65]
Citations
Cites
Noseworthy, J. H., Lucchinetti, C., Rodriguez, M., & Weinshenker, B. G. (2000) · New England Journal of Medicine · doi:10.1056/nejm200009283431307 · Cited by 2,899
Kebir, H., Kreymborg, K., Ifergan, I., Dodelet-Devillers, A., Cayrol, R., Bernard, M., Giuliani, F., Arbour, N., Becher, B., & Prat, A. (2007) · Nature Medicine · doi:10.1038/nm1651 · Cited by 1,759 · cited 4×
“Recently, it was shown that both IL-17A and IL-22 can disturb BBB integrity, but the exact mechanism by which this occurs is not clear (5).”
BackgroundInfluentialSelf-citationMultiple Sclerosis — The Plaque and Its Pathogenesis
Frohman, E. M., Racke, M. K., & Raine, C. S. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052130 · Cited by 1,740 · cited 1×
“Multiple sclerosis (MS) is an autoimmune inflammatory disease of the CNS that is characterized by sclerotic lesions found throughout the brain white matter (1).”
BackgroundIL-23 is essential for T cell–mediated colitis and promotes inflammation via IL-17 and IL-6
Yen, D., Cheung, J., Scheerens, H., Poulet, F., McClanahan, T., Mckenzie, B., Kleinschek, M. A., Owyang, A., Mattson, J., Blumenschein, W., et al. (2006) · Journal of Clinical Investigation · doi:10.1172/jci21404 · Cited by 1,542
IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis
Komiyama, Y., Nakae, S., Matsuki, T., Nambu, A., Ishigame, H., Kakuta, S., Sudo, K., & Iwakura, Y. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.1.566 · Cited by 1,536
TH-17 cells in the circle of immunity and autoimmunity
Bettelli, E., Oukka, M., & Kuchroo, V. K. (2007) · Nature Immunology · doi:10.1038/ni0407-345 · Cited by 1,517 · cited 1×
“A correlative link between IL-17A expression and the development of EAE has been well documented, as Th17 cells are abundant in the CNS of mice before and during the peak of the disease ( 35 ).”
BackgroundTzartos, J. S., Friese, M. A., Craner, M. J., Palace, J., Newcombe, J., Esiri, M. M., & Fugger, L. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.070690 · Cited by 1,187 · cited 1×
“Th17 cells, which produce the cytokines IL-17A, IL-17F, and IL-22, were shown to infiltrate the CNS in patients with MS and in mice with EAE (23, 24).”
BackgroundAn essential role for free radicals and derived species in signal transduction
Lander, H. M. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.2.9039953 · Cited by 902 · cited 1×
“We and others have demonstrated previously that ROS-induced activation of the endothelial contractile machinery leads to BBB disruption (14, 16, 26, 27, 36).”
BackgroundGarcia, J. G. N., Liu, F., Verin, A. D., Birukova, A., Dechert, M. A., Gerthoffer, W. T., Bamberg, J. R., & English, D. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12450 · Cited by 886 · cited 1×
“The endothelial contractile machinery is strongly regulated by the phosphorylation of myosin light chains (MLCs) ( 28 ).”
BackgroundRouvier, E., Luciani, M. F., Mattéi, M. G., Denizot, F., & Golstein, P. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.12.5445 · Cited by 775
Research works printed but not linked: 1
- 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q · DOI
Cited by
Items 101–200 of 528
Babaloo, Z., Aliparasti, M. R., Babaiea, F., Almasi, S., Baradaran, B., & Farhoudi, M. (2015) · Immunology Letters · doi:10.1016/j.imlet.2015.01.001 · Cited by 83
The peripheral immune response after stroke—A double edge sword for blood‐brain barrier integrity
Li, Y., Zhu, Z., Huang, T., Zhou, Y., Wang, X., Yang, L., Chen, Z., Yu, W., & Li, P. (2018) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13081 · Cited by 83
Choi, E. Y., Lim, J.-H., Neuwirth, A., Economopoulou, M., Chatzigeorgiou, A., Chung, K.-J., Bittner, S., Lee, S.-H., Langer, H., Samus, M., et al. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.146 · Cited by 82
“Moreover, we found increased BBB vascular permeability in Del-1 −/− mice in the course of EAE; this finding could be related to the IL-17-mediated BBB breakdown, published previously 34, 42 .”
Maternal immune stimulation during pregnancy shapes the immunological phenotype of offspring
Mandal, M., Donnelly, R., Elkabes, S., Zhang, P., Davini, D., David, B. T., & Ponzio, N. M. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2013.04.012 · Cited by 81
Wojkowska, D. W., Szpakowski, P., Ksiazek-Winiarek, D. J., Leszczynski, M., & Glabinski, A. R. (2014) · Mediators of Inflammation · doi:10.1155/2014/590409 · Cited by 81
Jha, M. K., Minhajuddin, A., Gadad, B. S., Greer, T. L., Mayes, T. L., & Trivedi, M. H. (2017) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2017.07.005 · Cited by 79
Interleukin‐17 and ischaemic stroke
Zhang, Q., Liao, Y., Liu, Z., Dai, Y., Li, Y., Li, Y., & Tang, Y. (2020) · Immunology · doi:10.1111/imm.13265 · Cited by 87
Pietrowski, E., Bender, B., Huppert, J., White, R., Luhmann, H. J., & Kuhlmann, C. R. W. (2010) · Journal of Vascular Research · doi:10.1159/000317400 · Cited by 85
“Briefly, 5,000 VSMC per well were used in the fences assay. Similar to the proliferation assay, cells were kept in serum reduced medium and treated with IL-17A (50–100 ng/ml) for 24 h. Thereafter, cells were stained using calcein green. Cell expansion was quantified using an InfiniteF200 plate reader. H 2 DCF Measurem…”
MethodSelf-citationZimmermann, J., Krauthausen, M., Hofer, M. J., Heneka, M. T., Campbell, I. L., & Müller, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057307 · Cited by 75
“Previous studies demonstrated that IL-17A stimulation induces the disruption of blood brain barrier integrity in cerebral microvascular endothelium [39,46].”
BackgroundResultGaskill, P. J., Calderon, T. M., Coley, J. S., & Berman, J. W. (2013) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-013-9443-y · Cited by 79
“Th17 cell localization within the CNS resulted in damage to neurons and increased neuroinflammation through CD4+ T cell recruitment (Kebir et al. 2007; Huppert et al. 2010).”
Th17 cell pathogenicity in autoimmune disease
Park, E., & Ciofani, M. (2025) · Experimental & Molecular Medicine · doi:10.1038/s12276-025-01535-9 · Cited by 75
“The penetration of the BBB is also facilitated by IL-17A through the production of reactive oxygen species (ROS) and matrix metalloproteinases from endothelial cells and fi broblasts 14,31,32 .”
Autoimmune and inflammatory mechanisms of CNS damage
Kapadia, M., & Šakić, B. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.08.008 · Cited by 81
“through the production of ROS within endothelial cells, ultimately resulting in down regulation of tight junction molecules (Huppert et al., 2010; Kebir et al., 2007).”
BackgroundRegulation and function of IL-17A- and IL-22-producing γδ T cells
Ness-Schwickerath, K. J., & Morita, C. T. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0700-z · Cited by 72
Baig, S. S., Kamarova, M., Ali, A., Su, L., Dawson, J., Redgrave, J. N. E., & Majid, A. (2021) · Autonomic Neuroscience · doi:10.1016/j.autneu.2021.102909 · Cited by 78
Elain, G., Jeanneau, K., Rutkowska, A., Mir, A. K., & Dev, K. K. (2014) · Glia · doi:10.1002/glia.22637 · Cited by 73
“IL17 signaling plays a role in the recruitment of both neutrophils and macrophages during inflammation (Witowski et al., 2004), subsequently neutrophils mediate disruption of the BBB (Yong et al., 2001) and production of reactive oxygen species (ROS) in CNS endothelial cells (Huppert et al., 2010).”
BackgroundParticipation of interleukin 17A in neuroimmune interactions
Moynes, D. M., Vanner, S. J., & Lomax, A. E. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.03.004 · Cited by 74
Dagur, P. K., Biancotto, A., Wei, L., Nida Sen, H., Yao, M., Strober, W., Nussenblatt, R. B., & Philip McCoy, J. (2011) · Journal of Autoimmunity · doi:10.1016/j.jaut.2011.09.003 · Cited by 69
“It is also worth noting that IL-17A and TNF-α are known to increase permeability of endothelial layers [30] and therefore might facilitate trans-endothelial migration.”
BackgroundEmerging Applications of Therapeutic Ultrasound in Neuro-oncology: Moving Beyond Tumor Ablation
Hersh, D. S., Kim, A. J., Winkles, J. A., Eisenberg, H. M., Woodworth, G. F., & Frenkel, V. (2016) · Neurosurgery · doi:10.1227/neu.0000000000001399 · Cited by 74
The Ins and Outs of Central Nervous System Inflammation—Lessons Learned from Multiple Sclerosis
Ramaglia, V., Rojas, O. L., Naouar, I., & Gommerman, J. L. (2021) · Annual Review of Immunology · doi:10.1146/annurev-immunol-093019-124155 · Cited by 79
Stravitz, R. T., Sanyal, A. J., Reisch, J., Bajaj, J. S., Mirshahi, F., Cheng, J., Lee, W. M., & The Acute Liver Failure Study Group (2013) · Liver International · doi:10.1111/liv.12214 · Cited by 69
“Specifically, IL-17-induced oxidative stress has been implicated in mediating disruption of the BBB in experimental models (24).”
BackgroundRigor, R. R., Beard, R. S., Litovka, O. P., & Yuan, S. Y. (2012) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00371.2011 · Cited by 67
“Likewise, in several studies (20, 23, 26, 28) of BBB dysfunction during focal brain tissue injury, hypoxia, and other neuroinflammatory conditions, BBB dysfunction was shown to depend on MLCK activity.”
BackgroundResultInfluentialExploiting the Pleiotropic Antioxidant Effects of Established Drugs in Cardiovascular Disease
Steven, S., Münzel, T. F., & Daiber, A. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160818185 · Cited by 72
“and activation of NADPH oxidase in brain endothelial cells [254,255].”
BackgroundKihara, Y., Yokomizo, T., Kunita, A., Morishita, Y., Fukayama, M., Ishii, S., & Shimizu, T. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.03.049 · Cited by 66
Carrillo-Salinas, F. J., Navarrete, C., Mecha, M., Feliú, A., Collado, J. A., Cantarero, I., Bellido, M. L., Muñoz, E., & Guaza, C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094733 · Cited by 66
“Phytocannabinoids that do not produce psychotropic effects are considered of special interest as novel therapeutic agents in CNS diseases.”
BackgroundInfluentialChen, C., Zhou, Y., Wang, J., Yan, Y., Peng, L., & Qiu, W. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01256 · Cited by 69
“This migration is mediated by IL-17 and IL-22 that disrupt tight junction proteins in CNS endothelial cells (11).”
BackgroundDistinct characteristics of hippocampal pathogenic th17 cells in a mouse model of depression
Beurel, E., Lowell, J. A., & Jope, R. S. (2018) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2018.04.012 · Cited by 65
Review: The Development of Risk Factors and Cytokines in Retinal Vein Occlusion
Tang, Y. P., Cheng, Y. F., Wang, S., Wang, Y., Liu, P., & Wu, H. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.910600 · Cited by 69
“Meanwhile, IL-17A could destroy BRB and provoke ROS in hypoxic and ischemia conditions (153).”
BackgroundCD44 Deficiency Contributes to Enhanced Experimental Autoimmune Encephalomyelitis
Flynn, K. M., Michaud, M., & Madri, J. A. (2013) · The American Journal of Pathology · doi:10.1016/j.ajpath.2013.01.003 · Cited by 61
Involvement of IL-17 in Secondary Brain Injury After a Traumatic Brain Injury in Rats
Tan, L., Zhang, Y., Han, D., Hua, R., Guo, B., Hu, S.-Q., Yan, X., & Xu, T. J. (2017) · NeuroMolecular Medicine · doi:10.1007/s12017-017-8468-4 · Cited by 67
“Previous studies have shown that IL-23 could expand and maintain its lineage of Th17 cells, promoting the production of IL-17, which is also called the IL-23/Th17 axis or IL-23/IL-17 axis (Isailovic et al. 2015; Leppkes et al. 2009).”
BackgroundInterleukin-17 Impairs Salivary Tight Junction Integrity in Sjögren’s Syndrome
Zhang, L. W., Cong, X., Zhang, Y., Wei, T., Su, Y., Serrao, A., Brito, A., Yu, G., Hua, H., & Wu, L. (2016) · Journal of Dental Research · doi:10.1177/0022034516634647 · Cited by 62
“Previous studies reported that IL-17 impairs the blood-brain and blood-testis barriers via downregulation of occludin and disrupts the intestinal barrier through upregulation of claudin-1 and -2 (Kinugasa et al. 2000; Huppert et al. 2010; Pérez et al. 2014).”
BackgroundClayton, A. M., Shao, Q., Paauw, N. D., Giambrone, A. B., Granger, J. P., & Warrington, J. P. (2018) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2018.03.028 · Cited by 69
“Furthermore, IL-17 has been shown to induce BBB disruption through the production of reactive oxygen species and down-regulation of occludin (Huppert et al., 2010) which we found to be decreased in the posterior cortex of rats exposed to placental ischemic pregnancy.”
Mechanisms of Dendritic Cell Trafficking Across the Blood–brain Barrier
Sagar, D., Foss, C., El Baz, R., Pomper, M. G., Khan, Z. K., & Jain, P. (2012) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-011-9302-7 · Cited by 60
“Proinflammatory cytokinemediated reactive oxygen species production has been shown to downregulate TJ proteins occludin and claudin-5 (Huppert et al. 2010; Schreibelt et al. 2007).”
BackgroundCytokine control of inflammation and repair in the pathology of multiple sclerosis.
Rodgers, J. M., & Miller, S. D. (2012) · PubMed Central · Cited by 70
Chemokine-Driven Migration of Pro-Inflammatory CD4+ T Cells in CNS Autoimmune Disease
Heng, A. H. S., Han, C. W., Abbott, C. A., McColl, S. R., & Comerford, I. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.817473 · Cited by 67
“It is possible that cytokines released by early infiltrating Th17 cells (such as TNFa or IL-17A) disrupt BBB integrity and then allow cells expressing chemokine receptors such as CCR2 or CXCR6 to enter the CNS directly from brain capillaries (107, 108).”
Backgroundβ1-Integrin– and KV1.3 channel–dependent signaling stimulates glutamate release from Th17 cells
Birkner, K., Wasser, B., Ruck, T., Thalman, C., Luchtman, D. W., Pape, K., Schmaul, S., Bitar, L., Krämer‐Albers, E., Stroh, A., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci126381 · Cited by 64
HMG-CoA reductase promotes protein prenylation and therefore is indispensible for T-cell survival
Lacher, S. M., Bruttger, J., Kalt, B., Berthelet, J., Rajalingam, K., Wörtge, S., & Waisman, A. (2017) · Cell Death & Disease · doi:10.1038/cddis.2017.221 · Cited by 58
Self-citationRole of the CXCR6/CXCL16 axis in autoimmune diseases
Bao, N., Fu, B., Zhong, X., Jia, S., Ren, Z., Wang, H., Wang, W., Shi, H. R., Li, J., Ge, F., et al. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110530 · Cited by 65
Riccio, P., & Rossano, R. (2019) · Nutrients · doi:10.3390/nu11112714 · Cited by 70
“Activated T-helper 17 an IL-17A can disrupt the BBB [91].”
BackgroundLanz, T. V., Becker, S., Osswald, M., Bittner, S., Schuhmann, M. K., Opitz, C. A., Gaikwad, S., Wiestler, B., Litzenburger, U. M., Sahm, F., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1302569110 · Cited by 56
“Although mediators from infiltrating T cells such as the T helper cytokine interleukin17 (IL-17) are certainly capable of sustaining BBB disruption in inflammatory lesions (38), the question whether BBB disruption precedes infiltration of pathogenic T cells and which factors are responsible for this disruption remains…”
BackgroundCutforth, T., DeMille, M. M., Agalliu, I., & Agalliu, D. (2016) · Future Neurology · doi:10.2217/fnl.16.4 · Cited by 55
Immunological aspects of rabies: a literature review
Katz, I. S. S., Guedes, F., Fernandes, E. R., & Silva, S. D. R. (2017) · Archives of Virology · doi:10.1007/s00705-017-3484-0 · Cited by 61
Zafiriou, E., Daponte, A., Siokas, V., Tsigalou, C., Dardiotis, E., & Bogdanos, D. P. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.699848 · Cited by 82
The interplay between T helper cells and brain barriers in the pathogenesis of multiple sclerosis
Angelini, G., Bani, A., Constantin, G., & Rossi, B. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1101379 · Cited by 66
“In line with this, inhibition of IL-17A in a model of EAE led to a reduced leukocyte infiltration of the CNS, lower CNS oxidative stress and milder clinical disease, further demonstrating a role for IL-17 in BBB breakdown (Huppert et al., 2010; Setiadi et al., 2019).”
BackgroundMethodAmyloid-Beta Disrupts Calcium and Redox Homeostasis in Brain Endothelial Cells
Fonseca, A. C. R. G., Moreira, P. I., Oliveira, C. R., Cardoso, S. M., Pinton, P., & Pereira, C. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8740-7 · Cited by 59
“the blood-brain barrier [46, 47].”
Plasticity of neutrophils reveals modulatory capacity
Perobelli, S. M., Galvani, R. G. A., Gonçalves-Silva, T., Xavier, C. R., Nóbrega, A., & Bonomo, A. C. (2015) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x20154524 · Cited by 63
“Upon stimulation by IL-1b, they infiltrate the spinal cord (53) and disrupt the blood-spinal cord barrier through ROS production that disrupts tight junction components (54).”
BackgroundTian, B., Zhou, M., Yang, Y., Lan, Y., Luo, Z., Tian, D., Wang, K., Cui, M., Chen, H., Fu, Z. F., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2017.02011 · Cited by 55
“Multiple inflammatory cytokines, including TNF-α, IL-6, IL-1β, IFN-γ, IL-17, and VEGF, disrupt BBB and TJ integrity in BMECs (46, 50, (54) (55) (56) , and inflammatory cytokine signaling at the BBB during infection facilitates leukocyte trafficking into the CNS, which is essential for the clearance of many pathogens (…”
Chronic exposure to IL-6 induces a desensitized phenotype of the microglia
Recasens, M., Almolda, B., Pérez‐Clausell, J., Campbell, I. L., González, B., & Castellano, B. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-020-02063-1 · Cited by 62
“As already commented, the upregulation of the pro-inflammatory cytokine IL-17 could be related with a higher number of CD8+ T cells and γδ T cells, one of the two cell-types that could produce this cytokine in the CNS [69, 93] and could be linked to alterations in the blood-brain barrier (BBB) [50], a well-described f…”
BackgroundInflammation: good or bad for ADHD?
Donev, R., & Thome, J. (2010) · ADHD Attention Deficit and Hyperactivity Disorders · doi:10.1007/s12402-010-0038-7 · Cited by 54
IL‐1 signaling is critical for expansion but not generation of autoreactive GM‐CSF+ Th17 cells
Mufazalov, I. A., Schelmbauer, C., Regen, T., Kuschmann, J., Wanke, F., Gabriel, L. A., Hauptmann, J., Müller, W., Pinteaux, E., Kurschus, F. C., et al. (2016) · The EMBO Journal · doi:10.15252/embj.201694615 · Cited by 67
“Mice were scored daily for clinical signs of EAE as described (Huppert et al , 2010) with modifications.”
Self-citationTh17 Cells and IL-17A in Ischemic Stroke
Wang, J., Gao, Y., Yuan, Y., Wang, H., Wang, Z., & Zhang, X. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03723-y · Cited by 59
“In addition, IL-17 has been shown to support monocyte migration in the blood–brain barrier through an intracellular adhesion molecule (ICAM)-1-dependent mechanism [54].”
BackgroundGross, C. C., Schulte-Mecklenbeck, A., Steinberg, O. V., Wirth, T., Lauks, S., Bittner, S., Schindler, P., Baranzini, S. E., Groppa, S., Bellmann-Strobl, J., et al. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.ade8560 · Cited by 52
Cellular Pathways Promoting Pulmonary Vascular Remodeling by Hypoxia
Shimoda, L. A. (2020) · Physiology · doi:10.1152/physiol.00039.2019 · Cited by 59
Mahmoodi, M., Amiri, H., Ayoobi, F., Rahmani, M., Taghipour, Z., Ghavamabadi, R. T., Jafarzadeh, A., & Sankian, M. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.11.051 · Cited by 57
IL17A impairs blood–testis barrier integrity and induces testicular inflammation
Pérez, C. V., Pellizzari, E. H., Cigorraga, S. B., Galardo, M. N., Naito, M., Lustig, L., & Jacobo, P. V. (2014) · Cell and Tissue Research · doi:10.1007/s00441-014-1995-5 · Cited by 52
Leboyer, M., Godin, O., Terro, E., Boukouaci, W., Lu, C.-L., André, M., Aouizerate, B., Berna, F. S., Barau, C., Capdevielle, D., et al. (2021) · Schizophrenia Bulletin Open · doi:10.1093/schizbullopen/sgab012 · Cited by 55
Roles of the gut microbiota in human neurodevelopment and adult brain disorders
Mallick, R., Basak, S., Das, R. K., Banerjee, A., Paul, S., Pathak, S., & Duttaroy, A. K. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1446700 · Cited by 58
Interleukin-17: The Role for Pathological Angiogenesis in Ocular Neovascular Diseases
Li, Y., & Zhou, Y. (2019) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.247.87 · Cited by 55
“IL-17 could induce blood-brain barrier disruption, thereby participating in the development of inflammation of the central nervous system (Kebir et al. 2007; Huppert et al. 2010).”
BackgroundCharabati, M., Grasmuck, C., Ghannam, S., Bourbonnière, L., Fournier, A. P., Lécuyer, M., Tastet, O., Kébir, H., Rébillard, R., Hoornaert, C., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abj0473 · Cited by 52
Cytokine dynamics and targeted immunotherapies in autoimmune encephalitis
Ciano-Petersen, N. L., Muñiz‐Castrillo, S., Birzu, C., Vogrig, A., Farina, A., Villagrán‐García, M., Joubert, B., Psimaras, D., & Honnorat, J. (2022) · Brain Communications · doi:10.1093/braincomms/fcac196 · Cited by 58
Zeng, X., Li, J., Shan, W., Lai, Z., & Zuo, Z. (2023) · Microbiome · doi:10.1186/s40168-023-01648-1 · Cited by 53
“Possible mechanisms for circulating IL-17 to induce brain injury include enhancing oxidative stress and causing injury to the blood–brain barrier [37].”
BackgroundChechneva, O. V., Mayrhofer, F., Daugherty, D. J., Pleasure, D., Hong, J., & Deng, W. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.06.004 · Cited by 51
TREK-King the Blood–Brain-Barrier
Bittner, S., Ruck, T., Fernández‐Orth, J., & Meuth, S. G. (2014) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-014-9530-8 · Cited by 52
“In another study, treatment of MOG peptide-induced EAE with ML-7, a specific inhibitor of MLCK, resulted in a reduction of CNSinvading leukocytes ad clinical disease symptoms (Huppert et al. 2010).”
Wu, H., Deng, R., Chen, X., Wong, W. C., Chen, H., Gao, L., Nie, Y., Wu, W., & Shen, J. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.3734-15.2016 · Cited by 49
“Among various immune cells, antigen-specific CD4 T cells, specifically TH1 and TH17 cells, had been demonstrated as key drivers in EAE and MS development (Huppert et al., 2010).”
BackgroundWang, X., Ma, C., Wu, J., & Zhu, J. (2013) · Journal of Neuroscience Research · doi:10.1002/jnr.23233 · Cited by 52
“Notably, IL-17A and IL-17F may have overlapping but different roles in the development of diseases (Yang et al., 2008a; Ishigame et al., 2009).”
BackgroundRole of Interleukin- (IL-) 17 in the Pathogenesis and Targeted Therapies in Spondyloarthropathies
Chyuan, I., & Chen, J.-Y. (2018) · Mediators of Inflammation · doi:10.1155/2018/2403935 · Cited by 54
“In the central nervous system, IL-17 can disrupt the blood-brain barrier tight junction and further facilitates local migration of CD4 T cells, leading to neuroinflammation [43].”
BackgroundAltered astrocytic function in experimental neuroinflammation and multiple sclerosis
das Neves, S. P., Sousa, J. C., Sousa, N., Cerqueira, J. J., & Marques, F. (2021) · Glia · doi:10.1002/glia.23940 · Cited by 49
“The BBB integrity is compromised during MS (Baecher-Allan et al., 2018; Kirk, Plumb, Mirakhur, & McQuaid, 2003; Plumb, McQuaid, Mirakhur, & Kirk, 2002), and also in EAE (Huppert et al., 2010).”
BackgroundAssociation of T and non-T cell cytokines with anhedonia: Role of gender differences
Jha, M. K., Miller, A. H., Minhajuddin, A., & Trivedi, M. H. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.05.017 · Cited by 47
“Additionally, while the role of IL-17 in disruption of blood-brain barrier is well recognized (Huppert et al., 2010; Kebir et al., 2007), the ratio of Th17 to Th1 cells is considered critical in the infiltration of brain parenchyma by peripheral immune cells and subsequent neuroinflammation (Stromnes et al.”
BackgroundCytokines and Chemokines in the Pathogenesis of Experimental Autoimmune Encephalomyelitis
Karpus, W. J. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1900914 · Cited by 51
“The functional significance of generating an IL-17 response with respect to EAE development may lie in the suggestion that this effector cytokine induces IL-6, IL-1b, CXCL2, and CCL2 production, which in turns leads to an inflammatory cascade resulting in attraction of both T cells and myeloid-derived leukocytes to th…”
BackgroundThomaz, A. C., Iyer, V., Woodward, T. J., & Hohmann, A. G. (2021) · Experimental Neurology · doi:10.1016/j.expneurol.2021.113787 · Cited by 51
IL-17A Damages the Blood–Retinal Barrier through Activating the Janus Kinase 1 Pathway
Byrne, E. M., Llorián‐Salvador, M., Tang, M., Margariti, A., Chen, M., & Xu, H. (2021) · Biomedicines · doi:10.3390/biomedicines9070831 · Cited by 48
“Three days of treatment with 100 ng/mL IL-17A was sufficient for tight junction dysmorphia and barrier dysfunction [49].”
BackgroundTH Cells and Cytokines in Encephalitogenic Disorders
Krishnarajah, S., & Becher, B. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.822919 · Cited by 55
“Evidence links IL-17 with barrier function in other organs such as the lung and gut (48, 49), with further experimental data pointing towards IL-17 playing a role in altering of the neurovascular junction being convincing (50, 51).”
BackgroundSelf-citationSchüler, R., Efentakis, P., Wild, J., Lagrange, J., Garlapati, V. S., Molitor, M., Kossmann, S., Oelze, M. W., Stamm, P., Li, H., et al. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/6721531 · Cited by 54
“Several studies describe direct effects of IL-17A on endothelial NO and ROS/RNS production: acute IL-17A treatment was described to increase the inhibitory eNOS Thr495 phosphorylation in endothelial cells, decreased NO-dependent relaxation responses in isolated mouse aorta [17], and IL-17A-induced ROS/RNS formation in…”
Self-citationIL-17A regulates Eimeria tenella schizont maturation and migration in avian coccidiosis
del Cacho, E., Gallego, M., Lillehoj, H. S., Quílez, J., Lillehoj, E. P., Ramo, A., & Sánchez-Acedo, C. (2014) · Veterinary Research · doi:10.1186/1297-9716-45-25 · Cited by 46
The role of T cells in acute ischemic stroke
Wang, Y.-R., Cui, W., Wu, H., Xu, X., & Xu, X.-Q. (2023) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2023.03.005 · Cited by 48
Nishioku, T., Furusho, K., Tomita, A., Ohishi, H., Dohgu, S., Shuto, H., Yamauchi, A., & Kataoka, Y. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.05.044 · Cited by 44
Camperio, C., Muscolini, M., Volpe, E., Mitri, D. D., Mechelli, R., Buscarinu, M. C., Ruggieri, S., Piccolella, E., Salvetti, M., Gasperini, C., et al. (2014) · Immunology Letters · doi:10.1016/j.imlet.2013.12.020 · Cited by 47
Poststroke Neuropsychiatric Symptoms: Relationships with IL-17 and Oxidative Stress
Swardfager, W., Herrmann, N., Andreazza, A. C., Swartz, R. H., Khan, M. M., Black, S. E., & Lanctôt, K. L. (2014) · BioMed Research International · doi:10.1155/2014/245210 · Cited by 45
Duan, J., Kang, J. M., Qin, W. D., Deng, T., Liu, H., Li, B., Yu, W. J., Gong, S., Yang, X., & Chen, M. (2018) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2018.07.089 · Cited by 47
Zeng, C., Chen, L., Chen, B., Cai, Y., Li, P., Yan, L., & Zeng, D. (2018) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmy137 · Cited by 44
The Role of IL-17A in Mediating Inflammatory Responses and Progression of Neurodegenerative Diseases
Zheng, M., & Luo, L. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26062505 · Cited by 49
“ECs exhibit low baseline IL-17RA expression, which increases in active MS lesions [88].”
Optical imaging to map blood-brain barrier leakage
Jaffer, H., Adjei, I. M., & Labhasetwar, V. D. (2013) · Scientific Reports · doi:10.1038/srep03117 · Cited by 50
Increased Interleukin-17 in Peripheral Blood and Cerebrospinal Fluid of Neurosyphilis Patients
Wang, C., Zhu, L., Gao, Z., Guan, Z., Lu, H., Shi, M., Gao, Y., Xu, H., Yang, X., & Zhou, P. (2014) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0003004 · Cited by 49
“IL-17 can disrupt the tight junction molecules and activates the endothelial contractile machinery, leading to disruption of blood brain barrier (BBB) [28].”
BackgroundAstrocytes and Inflammatory T Helper Cells: A Dangerous Liaison in Multiple Sclerosis
Kunkl, M., Amormino, C., Tedeschi, V., Fiorillo, M. T., & Tuosto, L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.824411 · Cited by 52
Strategies for enhancing antibody delivery to the brain
Frank, R. T., Aboody, K. S., & Najbauer, J. (2011) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2011.07.002 · Cited by 48
Zubcevic, J. A., Santisteban, M. M., Pérez, P. D., Arocha, R., Hiller, H., Malphurs, W. L., Colón-Pérez, L. M., Sharma, R. K., de Kloet, A. D., Krause, E. G., et al. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00592 · Cited by 44
“Furthermore, IL17 is able to induce expression of a host of HTN-associated inflammatory cytokines (Madhur et al., 2010), and is linked to breakdown of BBB in animal and human disease (Kebir et al., 2007; Huppert et al., 2010).”
BackgroundInfluentialCancer-related cognitive impairment is associated with perturbations in inflammatory pathways
Oppegaard, K., Harris, C. S., Shin, J., Paul, S. M., Cooper, B. A., Chan, A., Anguera, J. A., Levine, J., Conley, Y., Hammer, M., et al. (2021) · Cytokine · doi:10.1016/j.cyto.2021.155653 · Cited by 42
Redox Regulation of Endothelial Canonical Transient Receptor Potential Channels
Cioffi, D. L. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3740 · Cited by 46
Neuroprotective effect of baicalin on compression spinal cord injury in rats
Cao, Y., Li, G., Wang, Y., Fan, Z., Yu, D., Wang, Z.-D., & Bi, Y. (2010) · Brain Research · doi:10.1016/j.brainres.2010.07.108 · Cited by 42
Th17 Cells in Viral Infections—Friend or Foe?
Paiva, I. A., Badolato-Corrêa, J., Familiar-Macedo, D., & de‐Oliveira‐Pinto, L. M. (2021) · Cells · doi:10.3390/cells10051159 · Cited by 46
“In addition, we have the inflammatory chemokine receptors CXCR3 and CCR5, which are selectively expressed in Th1 and Th1/Th17 cells [144], and CCR7, which is also involved in the migration of T cells to the CNS and in MS [145].”
BackgroundHan, R. K., Cheng, Y. F., Zhou, S., Guo, H., He, R., Jun, L., & Zhang, L. M. (2013) · Journal of Clinical Immunology · doi:10.1007/s10875-013-9965-3 · Cited by 44
Zhang, C., Feng, W., Vodovozova, E. L., Tretiakova, D. S., Boldyrevd, I., Li, Y., Kurths, J., Yu, T., SEMYACHKINA-GLUSHKOVSKAYA, O. V., & Zhu, D. Y. (2018) · Biomedical Optics Express · doi:10.1364/boe.9.004850 · Cited by 44
Joshi, P., Bisht, A., Joshi, S., Semwal, D. K., Nema, N. K., Dwivedi, J., & Sharma, S. K. (2022) · Phytotherapy Research · doi:10.1002/ptr.7522 · Cited by 41
Multiple Sclerosis and the Blood-Central Nervous System Barrier
Palmer, A. M. (2013) · Cardiovascular Psychiatry and Neurology · doi:10.1155/2013/530356 · Cited by 49
“BCNSB disruption permits the movement of more leukocytes into the CNS parenchyma, which then leads to multifocal perivascular in�ltrates, predominantly T cells and macrophages [36, 62–64].”
BackgroundmiRNAs Alter T Helper 17 Cell Fate in the Pathogenesis of Autoimmune Diseases
Huang, J., Xu, X., & Yang, J. Y. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.593473 · Cited by 43
“As IL-17 and IL-22 disrupt tight junction proteins in CNS endothelial cells (74, 75), activated Th17 cells freely migrate through the blood-brain barrier into MS lesions (76).”
BackgroundRao, E., Singh, P., Li, Y., Zhang, Y., Chi, Y., Suttles, J., & Li, B. (2015) · BMC Immunology · doi:10.1186/s12865-015-0091-2 · Cited by 42
“In addition, CD8+ T cells in the CNS also displayed reduced expression of IFNγ in EI-03 treated mice (Figure 5H).”
BackgroundInfluentialImpact of Exercise on Innate Immunity in Multiple Sclerosis Progression and Symptomatology
Barry, A., Cronin, O., Ryan, A., Sweeney, B. J., Yap, S. M., O’Toole, O., Allen, A. P., Clarke, G. A., O’Halloran, K. D., & Downer, E. J. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00194 · Cited by 47
“In addition IL-17 has been identified to play a crucial role in the development of EAE by disrupting the BBB (Huppert et al., 2010).”
InfluentialKamel, K. M., Gad, A. M., Mansour, S. M., Safar, M. M., & Fawzy, H. M. (2018) · Inflammation · doi:10.1007/s10753-018-0841-4 · Cited by 42
Th17 Cells in Depression: Are They Crucial for the Antidepressant Effect of Ketamine?
Cui, M., Dai, W., Kong, J., & HongZhi, C. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.649144 · Cited by 38
Functional Implications of the IL-23/IL-17 Immune Axis in Schizophrenia
Debnath, M., & Berk, M. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0309-1 · Cited by 43
Barkaway, A., Attwell, D., & Korte, N. (2022) · Neurophotonics · doi:10.1117/1.nph.9.3.031914 · Cited by 39
“Infiltrating T cells can perturb the BBB via the action of cytokines IL-17 and IL-22,(304) which release ROS from ECs, disrupting tight junctions.(305) In addition, prolonged stalling of neutrophils in vessels may impair the integrity of the BBB”
Background
Metadata
- Authors
- Huppert, J., Closhen, D., Croxford, A., White, R., Kulig, P., Pietrowski, E., Bechmann, I., Becher, B., Luhmann, H. J., Waisman, A., & Kuhlmann, C. R. W.
- Affiliations
- Johannes Gutenberg University Mainz (DE)
- University of Zurich (CH)
- Leipzig University (DE)
- Corresponding author
- Waisman, Ari
- Kuhlmann, Christoph R. W.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2009-11-25
- Volume
- 24
- Issue
- 4
- Pages
- 1023-1034
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2071205488
- Semantic Scholar
- 28487cafa06774aea634538871f39aa337f374e1
- Cited by
- 529
- References
- 41
- Citations by year
- 2026: 29 · 2025: 41 · 2024: 43 · 2023: 40 · 2022: 43 · 2021: 44 · 2020: 21 · 2019: 21 · 2018: 31 · 2017: 28 · 2016: 32 · 2015: 31 · 2014: 27 · 2013: 35 · 2012: 15
- FWCI
- 13.42
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Locations
- The FASEB Journal (publishedVersion)
- PubMed (publishedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion)
- Zurich Open Repository and Archive (University of Zurich)
- Funders
- Deutsche Forschungsgemeinschaft (SFB TR52/C2)
- Boehringer Ingelheim Stiftung
- Topics
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Health Sciences › Medicine › Immunology and Allergy › Cell Adhesion Molecules Research
- Keywords
- IL-17A, blood-brain barrier disruption, Th17 cells, experimental autoimmune encephalomyelitis, reactive oxygen species, NADPH oxidase, xanthine oxidase, oxidative stress, myosin light chain phosphorylation, myosin light chain kinase, ML-7, occludin, tight junctions, endothelial contractility, monocyte adhesion, lymphocyte transendothelial migration, bEnd.3 endothelial cells
- MeSH terms
- Animals, Azepines, Blood-Brain Barrier, Cell Line, Transformed, Encephalomyelitis, Autoimmune, Experimental, Enzyme Inhibitors, T-Lymphocytes, Helper-Inducer, Membrane Proteins, Mice, Inbred BALB C, Myosin-Light-Chain Kinase, Naphthalenes, Xanthine Oxidase, Down-Regulation, Reactive Oxygen Species, Oxidative Stress, NADPH Oxidases, Interleukin-17, Endothelial Cells, Mice, Antibodies, Neutralizing, Occludin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.